56% of women undergoing IVF experience depression symptoms yet fewer than 7% seek psychiatric help due to absent mental health integration

A 2016 California study of 352 women and 274 men undergoing fertility treatment found that 56.5% of women and 32.1% of men reported symptoms of depression, while 75.9% of women and 60.6% of men were diagnosed with anxiety symptoms. Despite these rates being dramatically higher than the general population, fewer than 7% of fertility patients seek psychiatric help, and professional societies like ASRM and ESHRE have not standardized requirements for embedding mental health providers in fertility care teams. Why it matters: untreated depression and anxiety during IVF treatment reduce treatment adherence and outcomes, so patients experiencing psychological distress are more likely to drop out of treatment prematurely (with studies showing up to 50% of patients discontinue IVF for psychological rather than medical or financial reasons), so treatment discontinuation means lower cumulative success rates and wasted prior investment, so the emotional toll extends to relationships (with fertility treatment being cited in up to 30% of divorces among affected couples), so a generation of would-be parents suffers preventable psychological harm because the fertility industry treats reproduction as a purely biological process. The structural root cause is that fertility clinics are structured as procedural medical practices optimized for throughput (egg retrievals, transfers), mental health services are not reimbursable under most fertility insurance coverage, and there is no regulatory requirement for clinics to screen patients for psychological distress or provide integrated counseling despite evidence that cognitive behavioral therapy groups achieve pregnancy rates of 55% vs. 20% for unsupported controls.